PharmAthene, SIGA Fight Over Bioterror Defense Drug
PharmAthene Inc. began battling SIGA Technologies Inc. at trial Monday, demanding the erstwhile merger partner fulfill a licensing agreement and share a potential multibillion-dollar federal contract for a smallpox treatment that...To view the full article, register now.
Already a subscriber? Click here to view full article